法国无就医障碍但HIV照护连续体仍存在差异:全国人群研究
该研究基于法国Dat'AIDS前瞻性队列2013至2017年入组的患者,分析年龄、性别和出生地对HIV照护连续体(就医、接受抗逆转录病毒治疗及病毒抑制)的影响。尽管法国提供免费医疗和普遍ART,但年轻、外国出生及特定感染途径人群在病毒抑制方面仍存在显著差异,需针对性干预。
要点
- 男性与女性在ART治疗时间占比分别为85.6%和82.8%,病毒抑制时间占比分别为69.9%和65%。
- 男男性行为者(MSM)、男女性行为者(MSW)和女性的病毒抑制时间占比分别为72.5%、63.7%和65%。
- 外国出生患者病毒抑制时间占比(62.9%)低于法国出生患者(74.6%)。
核心结论
- 在法国免费医疗和普遍ART背景下,HIV照护连续体仍因年龄、出生地和感染途径存在差异。
- 需针对特定患者条件设计临床和公共卫生干预。
研究设计与样本
- 样本包括2432名女性(30.2%)、3925名MSM(48.7%)和1709名MSW(21.2%)。
- 评估5年限制平均人时百分比:就医、接受ART、ART且病毒抑制。
主要发现
- 男性与女性ART治疗时间占比分别为85.6%和82.8%,病毒抑制时间占比分别为69.9%和65%。
- MSM、MSW和女性ART治疗时间占比分别为86.9%、82.6%和82.8%,病毒抑制时间占比分别为72.5%、63.7%和65%。
- 法国出生(47%)与外国出生患者ART治疗时间占比分别为87.9%和81.9%,病毒抑制时间占比分别为74.6%和62.9%。
- 年轻外国出生MSW和MSM病毒抑制时间占比最低,分别为53%和58.1%。
临床怎么用
- 临床应关注年轻、外国出生及特定感染途径的HIV患者,加强病毒抑制支持。
- 公共卫生干预需针对上述差异人群定制,以改善照护连续体结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Even in an 'optimal' health system, patients' characteristics may have an impact on their care. We investigated whether age, gender and place of birth have an impact in the HIV care continuum in France, a country with a universal free healthcare system. METHODS: We estimated differences in the 5 year restricted mean percentage of person-time spent (i) in care, (ii) receiving ART and (iii) on ART and virally suppressed among 2432 (30.2%) women, 3925 MSM (48.7%) and 1709 men who have sex with women (MSW; 21.2%) entering care in the Dat'AIDS French prospective cohort between 1 January 2013 and 31 December 2017. Trial registration: Clinicaltrials.gov reference NCT02898987. RESULTS: Men and women spent 85.6% and 82.8% of person-time on ART and 69.9% and 65% suppressed, respectively. MSM, MSW and women spent 86.9%, 82.6% and 82.8% of person-time on ART and 72.5%, 63.7% and 65% suppressed, respectively. Patients born in France (47%) and patients born abroad spent 87.9% and 81.9% of person-time on ART and 74.6% and 62.9% suppressed, respectively. Young men born abroad were found to spend the smallest person-time with non-detectable viral load (53% for MSW and 58.1% for MSM). CONCLUSIONS: Despite free access to care and universal ART in France, disparities remain in the HIV continuum care across age, country of birth and way of HIV acquisition. Clinical and public health interventions targeting specific patients' conditions are needed.
引用
- Cuzin L, Allavena C, Cotte L, et al. No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study. J Antimicrob Chemother. 2021. PMID: 33704444. doi:10.1093/jac/dkab061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。